In a multiple myeloma model, cancer cells upregulated the osteocyte production of fibroblast growth factor (FGF23) and vascular endothelial growth factor (VEGF-A) factors that are known to promote tumor proliferation and angiogenesis [120]. This evidence concerns the gene VEGFA and plasma cell myeloma.